Recommendations for prevention and control of influenza in children, 2021-2022

Yvonne A. Maldonado, Sean T. O'Leary, Monica I. Ardura, Ritu Banerjee, Kristina A. Bryant, James D. Campbell, Mary T. Caserta, Chandy C. John, Jeffrey S. Gerber, Athena P. Kourtis, Adam J. Ratner, Jose R. Romero, Samir S. Shah, Kenneth M. Zangwill, Dawn Nolt, Flor M. Munoz, Ruth Lynfield, William J. Steinbach, Theoklis E. Zaoutis

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

This statement updates the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccine and antiviral medications in the prevention and treatment of influenza in children during the 2021-2022 influenza season. A detailed review of the evidence supporting these recommendations is published in the accompanying technical report.1 The American Academy of Pediatrics recommends annual influenza immunization of all children without medical contraindications, starting at 6 months of age. Influenza vaccination is an important intervention to protect vulnerable populations and reduce the burden of respiratory illnesses during circulation of severe acute respiratory syndrome coronavirus 2, which is expected to continue during the 2021-2022 influenza season. Any licensed, recommended, ageappropriate vaccine available can be administered, without preference for one product or formulation over another. Antiviral treatment of influenza with any licensed, recommended, age-appropriate influenza antiviral medication is recommended for children with suspected or confirmed influenza who are hospitalized, have severe or progressive disease, or have underlying conditions that increase their risk of complications of influenza. Antiviral treatment may be considered for any previously healthy, symptomatic outpatient not at high risk for influenza complications, in whom an influenza diagnosis is confirmed or suspected, if treatment can be initiated within 48 hours of illness onset and for children whose siblings or household contacts either are younger than 6 months or have a high-risk condition that predisposes them to complications of influenza.

Original languageEnglish (US)
Article numbere2021053744
JournalPediatrics
Volume148
Issue number4
DOIs
StatePublished - Oct 1 2021

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Recommendations for prevention and control of influenza in children, 2021-2022'. Together they form a unique fingerprint.

Cite this